Treatment of Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease: 4th International Symposium, Munich, October 1992
Product details
| Management number | 233460201 | Release Date | 2026/06/27 | List Price | US$97.08 | Model Number | 233460201 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Where diet and combined drug therapy have failed to prevent coronary heart disease in patients with severe hypercholesterolaemia (familial hypercholesterolaemia, familial defective apolipoprotein B-100), LDL apheresis has become the treatment of choice. Experience with LDL apheresis in this group of patients now spans more than 8 years. This volume summarizes data accumulated on LDL apheresis in relation to practical aspects, safety, side effects and effects on the course of coronary heart disease. Four different procedures are evaluated: immunoadsorption; dextran sulfate adsorption; heparin precipitation; and cascade filtration. In addition, an update on drug treatment is provided and aspects of the epidemiology, genetics and metabolism of tri-glyceride-rich lipoproteins are discussed. Read more
| ASIN | B017MDPKES |
|---|---|
| XRay | Not Enabled |
| Format | Print Replica |
| ISBN13 | 978-3318052152 |
| Edition | 1st |
| Language | English |
| File size | 14.0 MB |
| Page Flip | Not Enabled |
| Publisher | S. Karger |
| Word Wise | Not Enabled |
| Print length | 242 pages |
| Accessibility | Learn more |
| Publication date | December 16, 1993 |
| Enhanced typesetting | Not Enabled |
Bestseller ranking
Cardiovascular
Customers who viewed this product also viewed
Tragicomedy
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form